Prenatal Pro TM
Natural health product licensed in Canada
- Licence holder
- Designs for Health
- NPN or DIN-HM
- 80051531
- Status
- Active licence
- Licence date
- 6 June 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25.02 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 199.8 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Fer: up to 30 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cuivre Source : Diglycinate cuivrique | 166.7 mcg | 1000.2 µg |
| 2-hydroxy-N,N,N-triméthyléthanaminium Source : Choline | 16.7 mg | Not calculated |
| Biotine Source : Biotine | 50 mcg | 300 µg |
| Vitamine D Source : Cholécalciférol | 4.17 mcg | 25.02 µg |
| Sélénium Source : Glycinate de sélénium | 33.3 mcg | 199.8 µg |
| Myo-inositol Source : Inositol | 16.7 mg | Not calculated |
| Bore Source : Glycinate de Bore | 166.7 mcg | Not calculated |
| Mélange de concentré de tocophérol Source : Concentré de tocophérols, mélange | 41.7 mg | Not calculated |
| Acide d-pantothénique Source : D-Pantothénate de calcium | 8.3 mg | Not calculated |
| Folate Source : Brassica oleracea var. italica - Sommité (herbe) | 133.3 mcg | Not calculated |
| Fer Source : Diglycinate de fer (II) | 5 mg | 30,000 µg |
| Mélange de caroténoïdes Source : Mixed carotenoids | 9.5 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | 3 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Multi vitamin/mineral. A factor in the maintenance of good health. A source of antioxidants for the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. Helps to reduce the risk of neural tube defects when taken daily prior to becoming pregnant and during early pregnancy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have cancer. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are taking blood thinners. Consult a healthcare practitioner prior to use if you are undergoing hormonal treatments. Consult a health care practitioner prior to use if you have cardiovascular disease or diabetes. Keep out of reach of children. There is enough drug in this package to seriously harm a child.
Source
Official Health Canada record, licence 80051531
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.